Teleflex Incorporated (NYSE:TFX) Shares Acquired by Achmea Investment Management B.V.

Achmea Investment Management B.V. increased its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 89.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,250 shares of the medical technology company's stock after buying an additional 5,782 shares during the quarter. Achmea Investment Management B.V.'s holdings in Teleflex were worth $2,181,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Avior Wealth Management LLC raised its holdings in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock worth $38,000 after purchasing an additional 101 shares during the period. True Wealth Design LLC raised its holdings in Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock valued at $41,000 after buying an additional 166 shares during the period. IFP Advisors Inc lifted its position in Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after buying an additional 217 shares in the last quarter. Banque Cantonale Vaudoise grew its stake in Teleflex by 184.8% during the third quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company's stock worth $56,000 after buying an additional 146 shares during the period. Finally, Exchange Traded Concepts LLC increased its position in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after acquiring an additional 94 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Remove Ads

Teleflex Stock Down 0.7 %

Shares of TFX traded down $1.01 during midday trading on Wednesday, hitting $138.95. The company had a trading volume of 1,172,792 shares, compared to its average volume of 499,590. The company's 50 day moving average price is $165.38 and its 200 day moving average price is $195.90. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.91. The stock has a market cap of $6.44 billion, a price-to-earnings ratio of 27.62, a PEG ratio of 1.73 and a beta of 1.21. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.98%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Analyst Ratings Changes

TFX has been the topic of several recent research reports. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and decreased their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Wells Fargo & Company dropped their target price on Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Raymond James cut Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Finally, Truist Financial dropped their price objective on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research note on Monday, March 3rd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.